Cited by 232Diabetes and associated disordersGenetic Associations and EpidemiologyT-cell and B-cell Immunology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Association of a putative regulatory polymorphism in the PD‐1 gene with susceptibility to type 1 diabetes

Nielsen, C., Hansen, D., Husby, S., Jacobsen, B.B., Lillevang, S.T.·2003·Tissue Antigens

DOI 10.1046/j.1399-0039.2003.00136.x

Open this paper in CoChat — free account

Abstract

The immunoreceptor programmed cell death-1 (PD-1) is reported to play an important role in the regulation of peripheral tolerance in rodents, and it was recently shown that a polymorphism in a regulatory site of the PD-1 gene is associated with susceptibility to the autoimmune disease systemic lupus erythematosus (SLE) in humans. We investigated the existence of single-nucleotide polymorphisms (SNPs) in the PD-1 gene in patients with type 1 diabetes in comparison with healthy control subjects, by analyzing 94 children and adolescents with type 1 diabetes diagnosed before their eighteenth birthday (male : female = 52 : 42) and 155 control subjects. Polymorphisms in the complete PD-1 gene (minus the large intron 1) were detected by sequencing. In total, we identified 14 SNPs, of which six have been previously described, including an intronic 7146G/A SNP. We found this polymorphism to be associated with the development of type 1 diabetes [found in 12.2% of diabetic individuals vs 6.8% in controls; odds ratio (OR) = 1.92]. The associated allele is previously shown to alter a transcription factor-binding site (RUNX1/AML1), and the results of this study suggest that this allele could act as an additional susceptibility allele to type 1 diabetes.

Integrity signals

Registry

Crossref · 10.1046/j.1399-0039.2003.00136.x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
Salomon, B. L., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A. H., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,058
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher‐Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,889
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation
Olerup, O., & Zetterquist, H. (1992) · Tissue Antigens · doi:10.1111/j.1399-0039.1992.tb01940.x · Cited by 1,820
The B7–CD28 superfamily
Sharpe, A. H., & Freeman, G. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri727 · Cited by 1,759
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 873
CD4+CD25+ T Cells Inhibit Both the Induction and Effector Function of Autoreactive T Cells and Represent a Unique Lineage of Immunoregulatory Cells
Suri‐Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 858

Show all 20 references

Sorted by citations

The B7 family revisited
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,559
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Seidel, J. A., Otsuka, A., & Kabashima, K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00086 · Cited by 1,360
PD-1 and PD-1 ligands: from discovery to clinical application
Okazaki, T., & Honjo, T. (2007) · International Immunology · doi:10.1093/intimm/dxm057 · Cited by 1,310
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,081
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 939
The PD-1–PD-L pathway in immunological tolerance
Okazaki, T., & Honjo, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.001 · Cited by 736
Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies.
Byun, D. J., Wolchok, J. D., Rosenberg, L. M., & Girotra, M. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.205 · Cited by 685
Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) Collection: the PTPN22 620W Allele Associates with Multiple Autoimmune Phenotypes
Criswell, L. A., Pfeiffer, K. A., Lum, R. F., Gonzales, B., Novitzke, J. M., Kern, M., Moser, K. L., Begovich, A. B., Carlton, V. E. H., Li, W., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429096 · Cited by 601
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L., Barroso‐Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 550
Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
Ai, L., Xu, A., & Xu, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_3 · Cited by 542
PD-1 and its ligands in T-cell immunity
Keir, M. E., Francisco, L. M., & Sharpe, A. H. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.012 · Cited by 432
NFATc1 Regulates PD-1 Expression upon T Cell Activation
Oestreich, K. J., Yoon, H., Ahmed, R., & Boss, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4832 · Cited by 416
Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family
Bour‐Jordan, H., Esensten, J. H., Martinez‐Llordella, M., Penaranda, C., Stumpf, M., & Bluestone, J. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01011.x · Cited by 391
The role of the PD‐1 pathway in autoimmunity and peripheral tolerance
Fife, B. T., & Pauken, K. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05919.x · Cited by 366
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
Park, J., Omiya, R., Matsumura, Y., Sakoda, Y., Kuramasu, A., Augustine, M. M., Yao, S., Tsushima, F., Narazaki, H., Anand, S., et al. (2010) · Blood · doi:10.1182/blood-2010-01-265975 · Cited by 331
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Fife, B. T., Guleria, I., Bupp, M. G., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita∥, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 331
Role of PD-1 in Regulating T-Cell Immunity
Jin, H., Ahmed, R., & Okazaki, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_116 · Cited by 310
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
de Filette, J. M. K., Pen, J. J., Decoster, L., Vissers, T. F. H., Bravenboer, B., der Auwera, B. J. R. V., Gorus, F., Roep, B. O., Aspeslagh, S., Neyns, B., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0291 · Cited by 284
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 277
PD-1/PD-L and autoimmunity: A growing relationship
Zamani, M. R., Aslani, S., Salmaninejad, A., Javan, M. R., & Rezaei, N. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.09.009 · Cited by 276
Genetic and Epigenetic Regulation of PD-1 Expression
Bally, A. P. R., Austin, J. W., & Boss, J. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502643 · Cited by 254
PTPN22 Genetic Variation: Evidence for Multiple Variants Associated with Rheumatoid Arthritis
Carlton, V. E. H., Hu, X., Chokkalingam, A. P., Schrodi, S. J., Brandon, R. C., Alexander, H. C., Chang, M., Catanese, J. J., Leong, D. U., Ardlie, K., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/468189 · Cited by 240
Ethnic differences in allele frequency of autoimmune-disease-associated SNPs
Mori, M., Yamada, R., Kobayashi, K., Kawaida, R., & Yamamoto, K. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0246-8 · Cited by 235
Joint Genetic Susceptibility to Type 1 Diabetes and Autoimmune Thyroiditis: from Epidemiology to Mechanisms
Huber, A. K., Menconi, F., Corathers, S. D., Jacobson, E. M., & Tomer, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0015 · Cited by 235
Immune checkpoint inhibitors: An emerging cause of insulin-dependent diabetes
Kotwal, A., Haddox, C., Block, M., & Kudva, Y. C. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000591 · Cited by 228
Alternative splice variants of the human PD-1 gene
Nielsen, C., Ohm‐Laursen, L., Barington, T., Husby, S., & Lillevang, S. T. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.07.007 · Cited by 230
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Schnell, A., Bod, L., Madi, A., & Kuchroo, V. K. (2020) · Cell Research · doi:10.1038/s41422-020-0277-x · Cited by 234
The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity
Khoury, S. J., & Sayegh, M. H. (2004) · Immunity · doi:10.1016/s1074-7613(04)00116-5 · Cited by 209
Role of PD-1 in Immunity and Diseases
Chamoto, K., Al-Habsi, M., & Honjo, T. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_67 · Cited by 200
Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
Boussiotis, V. A., Chatterjee, P., & Li, L. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000059 · Cited by 190
Association of the PD‐1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope
Prokunina‐Olsson, L., Padyukov, L., Bennet, A. M., Fairé, U. D., Wiman, B., Prince, J. A., Alfredsson, L. S., Klareskog, L., & Alarcón-Riquelme, M. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20280 · Cited by 173
Literature Mining for the Discovery of Hidden Connections between Drugs, Genes and Diseases
Frijters, R., van Vugt, M. J. H., Smeets, R. L., van Schaik, R., de Vlieg, J., & Alkema, W. B. L. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000943 · Cited by 164
Update on human systemic lupus erythematosus genetics
Tsao, B. P. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000132648.62680.81 · Cited by 158
Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
Osum, K. C., Burrack, A. L., Martinov, T., Sahli, N. L., Mitchell, J. S., Tucker, C., Pauken, K. E., Papas, K. K., Balamurugan, A. N., Spanier, J. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26471-9 · Cited by 145
The B7/CD28 costimulatory family in autoimmunity
Keir, M. E., & Sharpe, A. H. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00242.x · Cited by 140
Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review
Stelmachowska‐Banaś, M., & Czajka-Oraniec, I. (2020) · Endocrine Connections · doi:10.1530/ec-20-0342 · Cited by 139
Association of PDCD1 with susceptibility to systemic lupus erythematosus
Ferreirós-Vidal, I., Gómez-Reino, J. J., Barros, F., Carracedo, Á., Carreira, P. E., Gonzáléz‐Escribano, F., Liz, M., Martin, J. J., Ordi‐Ros, J., Vicario, J. L., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20436 · Cited by 120
Runx3 Regulates Integrin αE/CD103 and CD4 Expression during Development of CD4−/CD8+ T Cells
Grueter, B., Petter, M., Egawa, T., Laule-Kilian, K., Aldrian, C. J., Würch, A., Ludwig, Y., Fukuyama, H., Wardemann, H., Waldschütz, R., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1694 · Cited by 121
PD-1/PD-L pathway and autoimmunity
Okazaki, T., & Wang, J. (2005) · Autoimmunity · doi:10.1080/08916930500124072 · Cited by 113
The nature of activatory and tolerogenic dendritic cell-derived signal II
Bakdash, G., Sittig, S. P., van Dijk, T., Figdor, C. G., & de Vries, I. J. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00053 · Cited by 126
Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy
Lowe, J. R., Perry, D. J., Salama, A. K. S., Mathews, C. E., Moss, L. G., & Hanks, B. A. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0196-z · Cited by 110
Low programmed cell death-1 (PD-1) expression in peripheral CD4 + T cells in Japanese patients with autoimmune type 1 diabetes
Fujisawa, R., Haseda, F., Tsutsumi, C., Hiromine, Y., Noso, S., Kawabata, Y., Mitsui, S., Terasaki, J., Ikegami, H., Imagawa, A., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12603 · Cited by 108
New insight in endocrine-related adverse events associated to immune checkpoint blockade
Elia, G., Ferrari, S. M., Galdiero, M. R., Ragusa, F., Paparo, S. R., Ruffilli, I., Varricchi, G., Fallahi, P., & Antonelli, A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101370 · Cited by 108
The regulation of lymphocyte activation by inhibitory receptors
Leibson, P. J. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.006 · Cited by 100
PD-1, gender, and autoimmunity
Dinesh, R. K., Hahn, B. H., & Singh, R. P. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.04.003 · Cited by 100
Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice
Brauner, H., Elemans, M., Lemos, S., Broberger, C., Holmberg, D., Flodström‐Tullberg, M., Kärre, K., & Höglund, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0804358 · Cited by 99
PD-1, but Not PD-L1, Expressed by Islet-Reactive CD4+ T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes
Pauken, K. E., Jenkins, M. K., Azuma, M., & Fife, B. T. (2013) · Diabetes · doi:10.2337/db12-1475 · Cited by 84
Breakdown in Peripheral Tolerance in Type 1 Diabetes in Mice and HumansPreprint
Jeker, L. T., Bour-Jordan, H., & Bluestone, J. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007807 · Cited by 82
Expression of PD-1, PD-L1, and PD-L2 in the Liver in Autoimmune Liver Diseases
Mataki, N., Kikuchi, K., Kawai, T., Higashiyama, M., Okada, Y., Kurihara, C., Hokari, R., Kawaguchi, A., Nagao, S., Kondo, T., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00948.x · Cited by 80
PD-1 regulation in immune homeostasis and immunotherapy
Gao, M., Shi, J., Xiao, X., Yao, Y., Chen, X., Wang, B., & Zhang, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216726 · Cited by 85
Current topics in human SLE genetics
Wong, M., & Tsao, B. P. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0031-6 · Cited by 75
Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility
Mitchell, A. L., Cordell, H. J., Soemedi, R., Owen, K., Skinningsrud, B., Wolff, A. S. B., Ericksen, M., Undlien, D. E., Husebye, E. S., & Pearce, S. H. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1404 · Cited by 75
Immune interactions at the maternal–fetal interface
Petroff, M. G. (2005) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2005.08.003 · Cited by 73
PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children
Ni, R., Ihara, K., Miyako, K., Kuromaru, R., Inuo, M., Kohno, H., & Hara, T. (2007) · Human Genetics · doi:10.1007/s00439-006-0309-8 · Cited by 73
Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
Alarcón-Riquelme, M. E. (2004) · Arthritis Research · doi:10.1186/ar1203 · Cited by 71
PD-1 ligands, negative regulators for activation of naïve, memory, and recently activated human CD4+ T cells
Cai, G., Karni, A., de Oliveira, E. M. L., Weiner, H. L., Hafler, D. A., & Freeman, G. J. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.09.004 · Cited by 71
Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes
Martins, C. P., New, L. A., O’Connor, E. C., Previte, D. M., Cargill, K. R., Tse, I., Sims‐Lucas, S., & Piganelli, J. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669456 · Cited by 70
Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes
Falcone, M., & Fousteri, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00569 · Cited by 72
Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD‐1.3A genotype in patients with systemic lupus erythematosus
Kristjansdottir, H., Steinsson, K., Gunnarsson, I., Gröndal, G., Erlendsson, K., & Alarcón-Riquelme, M. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27417 · Cited by 66
Genetics of susceptibility and severity in systemic lupus erythematosus
Croker, J. A., & Kimberly, R. P. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000169360.15701.27 · Cited by 65
Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation
Lin, S.-J., Peacock, C. D., Bahl, K., & Welsh, R. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062150 · Cited by 62
The negative costimulatory molecule PD‐1 modulates the balance between immunity and tolerance via miR‐21
Iliopoulos, D., Kavousanaki, M., Ιωάννου, Μ., Boumpas, D. T., & Verginis, P. (2011) · European Journal of Immunology · doi:10.1002/eji.201040646 · Cited by 62
The candidate genes TAF5L, TCF7, PDCD1 , IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes
Cooper, J. D., Smyth, D. J., Bailey, R., Payne, F., Downes, K., Godfrey, L. M., Masters, J., Zeitels, L. R., Vella, A. V., Walker, N. M., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-71 · Cited by 57
Meta-analysis of genetic polymorphisms in programmed cell death 1
Lee, Y. H., Bae, S., Kim, J., & Song, G. G. (2014) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-014-1415-y · Cited by 57
Dendritic cells and interferon-mediated autoimmunity
Gottenberg, J., & Chiocchia, G. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.013 · Cited by 57
Phenotypic and genetic analyses of T‐cell‐mediated immunoregulation in patients with Type 1 diabetes
Tsutsumi, Y., Jie, X., Ihara, K., Nomura, A., Kanemitsu, S., Takada, H., & Hara, T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01951.x · Cited by 58
Recent findings on genes associated with inflammatory disease
Yamada, R., & Ymamoto, K. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.061 · Cited by 56
Programmed Death-1 Gene Polymorphisms in Patients With Systemic Lupus Erythematosus in Taiwan
Wang, S., Chen, Y., Ou, T., Wu, C., Tsai, W., Liu, H., & Yen, J. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9048-9 · Cited by 55
The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow
Prokunina‐Olsson, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh076 · Cited by 53
Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population.
Ma, Y., Liu, X., Zhu, J., Li, W., Guo, L., Han, X., Song, B., Cheng, S., & Liu, J. (2015) · PubMed · Cited by 50
Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus
Sánchez, E., Abelson, A.-K., Sabio, J. M., González-Gay, M. Á., Ortego‐Centeno, N., Jiménez-Alonso, J. F., de Ramón, E., Sánchez-Román, J., López‐Nevot, M. Á., Gunnarsson, I., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22871 · Cited by 50
Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus
Perri, V., Russo, B., Crinò, A., Schiaffini, R., Giorda, E., Cappa, M., Rosado, M. M., & Fierabracci, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922584 · Cited by 51
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
Rui, Y., Honjo, T., & Chikuma, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315828110 · Cited by 48
Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients.
Hayashi, M., Kouki, T., Takasu, N., Sunagawa, S., & Komiya, I. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0649 · Cited by 48
PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis
Ishizaki, Y., Yukaya, N., Kusuhara, K., Kira, R., Torisu, H., Ihara, K., Sakai, Y., Sanefuji, M., Pipo-Deveza, J. R., Silao, C. L. T., et al. (2010) · Human Genetics · doi:10.1007/s00439-009-0781-z · Cited by 46
Phenotype, effector function, and tissue localization of PD-1-expressing human follicular helper T cell subsets
Wang, C., Hillsamer, P., & Kim, C. H. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-53 · Cited by 53
The impact of antisperm antibodies on human male reproductive function: an update
Silva, A. F., Ramalho‐Santos, J., & Amaral, S. (2021) · Reproduction · doi:10.1530/rep-21-0123 · Cited by 46
Constitutive Neuronal Expression of the Immune Regulator, Programmed Death 1 (PD-1), Identified During Experimental Autoimmune Uveitis
Ling, C., Pai, V., Levinson, R. D., Sharpe, A. H., Freeman, G. J., Braun, J. G., & Gordon, L. K. (2009) · Ocular Immunology and Inflammation · doi:10.1080/09273940802491884 · Cited by 46
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b −/− Pdcd1 −/− mice
Okazaki, T., Otaka, Y., Wang, J., Hiai, H., Takai, T., Ravetch, J. V., & Honjo, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051984 · Cited by 46
Program death 1 (PD1) haplotyping in patients with breast carcinoma
Haghshenas, M. R., Naeimi, S., Talei, A., Ghaderi, A. A., & Erfani, N. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0542-z · Cited by 45
Tag SNP screening of the PDCD1 gene for association with Graves’ disease
Newby, P., Roberts‐Davies, E. L., Brand, O. J., Heward, J. M., Franklyn, J. A., Gough, S. C. L., & Simmonds, M. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02848.x · Cited by 44
PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients
Fichna, M., Żurawek, M., Januszkiewicz‐Lewandowska, D., Fichna, P., & Nowak, J. (2010) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00935.x · Cited by 42
Immunoregulatory molecules are master regulators of inflammation during the immune response
de la Fuente, H., Cibrián, D., & Sánchez‐Madrid, F. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.032 · Cited by 43
CD4 + PD-1 + T Cells Acting as Regulatory Cells during the Induction of Anterior Chamber-Associated Immune Deviation
Meng, Q., Yang, P., Li, B., Zhou, H., Huang, X., Zhu, L., Ren, Y., & Kijlstra, A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0201 · Cited by 42
Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population
Liu, X., Hu, L., Li, Y., Chen, F., Ning, Y., & Yao, Q. (2009) · Rheumatology International · doi:10.1007/s00296-009-1264-1 · Cited by 41
Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions
Mi, Y., Han, J., Zhu, J., & Jin, T. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02495-7 · Cited by 44
Risk Factors and Primary Prevention Trials for Type 1 Diabetes
Wu, Y., Ding, Y., Gao, J. J., Tanaka, Y., & Zhang, W. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6610 · Cited by 50
Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology
Gardner, G., & Fraker, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722979 · Cited by 44
T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
McKinney, E. F., & Smith, K. G. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.81 · Cited by 36
Dexamethasone/1α‐25‐dihydroxyvitamin D3‐treated dendritic cells suppress colitis in the SCID T‐cell transfer model
Pedersen, A. E., Schmidt, E. G. W., Gad, M., Poulsen, S. S., & Claësson, M. H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02996.x · Cited by 38
Transcriptional and epigenetic regulation of PD-1 expression
Chi, Z., Lü, Y., Yang, Y., Li, B., & Lu, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03737-y · Cited by 38
MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population
Sánchez, E., Alizadeh, B. Z., Valdigem, G., Ortego‐Centeno, N., Jiménez-Alonso, J. F., de Ramón, E., García, A., López‐Nevot, M. Á., Wijmenga, C., Martin, J. J., et al. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.03.006 · Cited by 38
Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes
Momin, S., Flores, S., Bárbara Angel, B., Ethel Codner, D., Elena Carrasco, P., & Pérez‐Bravo, F. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.003 · Cited by 37
PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome.
Meng, Q., Liu, X., Yang, P., Hou, S., Du, L., Zhou, H., & Kijlstra, A. (2009) · PubMed Central · Cited by 37
A Promoter Region Polymorphism inPDCD-1Gene Is Associated with Risk of Rheumatoid Arthritis in the Han Chinese Population of Southeastern China
Liu, C., Jiang, J., Gao, L., Hu, X., Wang, F., Shen, Y., Yu, G., Zhao, Z., & Zhang, X. (2014) · International Journal of Genomics · doi:10.1155/2014/247637 · Cited by 36
Immunotherapy in patients with autoimmune disease
Rakshit, S., & Molina, J. R. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-2019-cptn-10 · Cited by 35
Human immune phenotyping reveals accelerated aging in type 1 diabetes
Shapiro, M. R., Dong, X., Perry, D. J., McNichols, J., Thirawatananond, P., Posgai, A. L., Peters, L. D., Motwani, K., Musca, R. S., MUIR, A. B., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170767 · Cited by 36
Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta‐analysis
Liu, J., Zhang, F., Liang, Y., Xiao, F., Zhang, S. ‐., Cheng, Y., Yuan, C., Chen, Q., Yang, S., & Zhang, X. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03087.x · Cited by 35
Influence of molecular genetics in Vogt-Koyanagi-Harada disease
Ng, J. Y., Luk, F. O. J., Lai, T. Y. Y., & Pang, C. (2014) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-014-0020-1 · Cited by 37

Authors: Nielsen, C., Hansen, D., Husby, S., Jacobsen, B. B., & Lillevang, S. T.
Affiliations: Odense University Hospital (DK)
Corresponding author: Lillevang, S.T.
ORCID: Nielsen, C.
Husby, S.
Lillevang, S.T.
Venue: Tissue Antigens
Publisher: Wiley
Published: 2003-11-11
Volume: 62
Issue: 6
Pages: 492-497
ISSN: 0001-2815 (ISSN-L)
1399-0039
DOI: 10.1046/j.1399-0039.2003.00136.x
OpenAlex: W2082012343
Cited by: 232
References: 20
Citations by year: 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 13 · 2020: 12 · 2019: 8 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 8 · 2013: 13 · 2012: 9
FWCI: 7.40
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Tissue Antigens (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: type 1 diabetes, single nucleotide polymorphisms, genetic susceptibility, regulatory polymorphisms, transcription factor binding sites, peripheral tolerance, autoimmune disease, children and adolescents
MeSH terms: Adolescent, Alleles, Antigens, Surface, Child, Diabetes Mellitus, Type 1, Female, Gene Frequency, Humans, Lupus Erythematosus, Systemic, Male, Antigens, CD, Linkage Disequilibrium, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apoptosis Regulatory Proteins, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of a putative regulatory polymorphism in the PD‐1 gene with susceptibility to type 1 diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks